Europe Approves $63 Billion AbbVie-Allergan Takeover
Europe Approves $63 Billion AbbVie-Allergan Takeover
GALWAY, IRELAND--January 22, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The $63 billion merger of pharmaceutical giant AbbVie (NYSE:ABBV) (Chicago, Illinois) and Ireland's Allergan plc (NYSE:AGN) (Dublin, Ireland) has taken a major step toward completion with the deal getting the "conditional" green light from the European Commission (EC).
Within this article: Details conditional EU permission, overlap in products, proposal for IBD treatment divestment and continued research
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects